Reports for HIKMA CANADA LIMITED
Company Name
HIKMA CANADA LIMITED
Totals |
||
Shortage reports |
82 |
|
| Actual shortage: | 12 (15%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (1%) | |
| Resolved: | 69 (84%) | |
Discontinuation Reports |
4 |
|
| To be discontinued: | 3 (75%) | |
| Discontinued: | 1 (25%) | |
| Reversed: | 0 (0%) | |
Late reports |
16 (19%) |
|
Overdue reports |
9 (60%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2019-02-19 | 2019-06-19 | 76329 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2019-12-20 | 2020-02-21 | 101864 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2022-03-30 | 2022-04-28 | 157571 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2022-06-20 | 2022-08-16 | 163112 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2023-08-03 | 2024-03-28 | 200978 |
| LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP | 20MG 0.01MG | SOLUTION | Resolved | 2017-12-22 | 2018-02-15 | 34258 |
| LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP | 20MG 0.01MG | SOLUTION | Resolved | 2018-03-08 | 2018-05-16 | 42273 |
| LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP | 0.01MG 20MG | SOLUTION | Actual shortage | 2021-05-14 | 2021-05-15 | 139438 |
| LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP | 0.01MG 20MG | SOLUTION | Resolved | 2022-04-14 | 2023-02-21 | 158881 |
| ERGONOVINE MALEATE INJECTION USP | 0.25MG | SOLUTION | Resolved | 2019-03-11 | 2019-04-18 | 78235 |
| ERGONOVINE MALEATE INJECTION USP | 0.25MG | SOLUTION | Resolved | 2021-05-14 | 2021-09-04 | 139434 |
| DIAZEPAM INJECTION USP | 5MG | SOLUTION | Resolved | 2018-09-27 | 2019-05-04 | 62442 |
| DIAZEPAM INJECTION USP | 5MG | SOLUTION | Actual shortage | 2020-05-20 | 2020-05-21 | 115413 |
| BACLOFEN INJECTION | 0.05MG | SOLUTION | Actual shortage | 2023-05-26 | 2023-05-27 | 193244 |
| ACETYLCYSTEINE SOLUTION USP | 200MG | SOLUTION | Resolved | 2018-07-12 | 2018-09-04 | 55518 |
| ACETYLCYSTEINE SOLUTION USP | 200MG | SOLUTION | Resolved | 2019-05-28 | 2021-04-22 | 85112 |
| ACETYLCYSTEINE SOLUTION USP | 200MG | SOLUTION | Resolved | 2022-10-06 | 2023-06-02 | 171228 |
| ACETYLCYSTEINE SOLUTION USP | 200MG | SOLUTION | Avoided shortage | 2022-10-21 | 2023-06-14 | 172409 |
| NALOXONE INJECTABLE | 0.4MG | SOLUTION | Resolved | 2022-12-05 | 2022-12-31 | 177165 |
| GENTAMICIN INJECTION USP | 10MG | SOLUTION | Resolved | 2020-11-09 | 2020-12-03 | 128174 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Discontinued | 2024-04-19 | 2024-04-22 | 225805 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 2G 0.25G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165188 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165193 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165196 |
Showing 1 to 4 of 4